```html

Facial Nerve Palsy (Bell’s Palsy): A Complete Medical Guide

Overview

Bell’s palsy is an acute, typically unilateral (one‑sided) weakness or paralysis of the facial muscles caused by inflammation of the seventh cranial nerve (the facial nerve). It develops rapidly—often reaching its worst point within 48 hours—and can affect facial expression, eye closure, taste, and tear production.

Who it affects: Although it can occur at any age, Bell’s palsy is most common in adults between 15 and 60 years old. Women and men are affected equally.

Prevalence: Worldwide, about 20–30 cases occur per 100,000 people each year. In the United States, roughly 40,000 new cases are diagnosed annually, making it one of the most frequent causes of acute facial paralysis.<sup>[1][2]</sup>

Symptoms

Symptoms usually appear suddenly, often overnight. They may be mild (slight weakness) or severe (complete paralysis). The classic presentation includes:

• Facial droop: Inability to raise the eyebrow, smile, or close the eye on the affected side.
• Difficulty with facial expressions: Trouble whistling, blowing, or drinking through a straw.
• Eye problems: Inability to fully close the eyelid (lagophthalmos) leading to dry eye, irritation, or corneal ulceration.
• Taste changes: Reduced sensation on the anterior two‑thirds of the tongue.
• Hyperacusis: Increased sensitivity to loud sounds because the stapedius muscle (innervated by the facial nerve) may be weak.
• Pain behind the ear or jaw: Often precedes the paralysis.
• Drooling: Due to impaired control of mouth muscles.
• Facial spasm or twitching: May occur during the recovery phase.
• Decreased tear production: May cause a gritty feeling in the eye.

Most people experience peak weakness within 2–3 days, and 70–80 % begin to improve within three weeks.

Causes and Risk Factors

The exact trigger for Bell’s palsy is unknown, but the prevailing theory is that a viral infection (most commonly herpes simplex virus‑1, HSV‑1) reactivates, causing inflammation, swelling, and compression of the facial nerve within the narrow bony canal of the temporal bone.

Potential precipitating factors

• Recent upper‑respiratory or ear infection.
• Cold sores (herpes labialis) indicating HSV‑1 reactivation.
• Pregnancy, especially in the third trimester.
• Diabetes mellitus.
• Hypertension.
• Immune‑mediated conditions (e.g., Guillain‑Barré syndrome, Lyme disease).
• Exposure to cold wind or rapid temperature changes (historical belief, limited scientific support).

Who is at higher risk?

• Age: 15‑60 years, with a slight increase after age 50.
• Pregnant women: Up to 3‑fold higher incidence, particularly in the third trimester.<sup>[3]</sup>
• People with diabetes: Odds ratio ≈ 2.0 for developing Bell’s palsy.<sup>[4]</sup>
• Those with a recent viral illness.

Diagnosis

Bell’s palsy is a diagnosis of exclusion—meaning that other causes of facial weakness must be ruled out.

Clinical evaluation

• History: Sudden onset, preceding ear pain, recent viral infection, pregnancy status.
• Physical exam: Evaluation of facial movements (raising eyebrows, closing eyes, smiling), corneal reflex, and taste testing.

Key tests to exclude other conditions

• Blood work: CBC, fasting glucose, HbA1c to assess diabetes, ESR/CRP for inflammation.
• Serology or PCR: For Lyme disease (especially in endemic areas) and, rarely, for HSV or varicella‑zoster.
• Imaging: MRI with gadolinium or high‑resolution CT if there is atypical presentation (e.g., gradual onset, bilateral involvement, or severe pain) to rule out tumors, stroke, or demyelinating disease.
• Electrodiagnostic studies: Electroneuronography (ENoG) or electromyography (EMG) performed 3 days after onset to predict prognosis in severe cases.

When the clinical picture fits classic Bell’s palsy (rapid unilateral weakness, no other neurological deficits), extensive testing may not be necessary.

Treatment Options

The main goals are to reduce nerve inflammation, protect the eye, and promote functional recovery.

Medications

• Corticosteroids: Prednisone 60‑80 mg daily for 5‑10 days, started within 72 hours of symptom onset, improves recovery odds by 10‑20 % and reduces incomplete recovery.<sup>[5]</sup>
• Antiviral agents: Acyclovir or valacyclovir are sometimes added (especially in severe cases or if HSV is suspected), though evidence of benefit is modest.<sup>[6]</sup>
• Pain control: NSAIDs or acetaminophen for ear or jaw pain.

Eye protection

• Artificial tears (preservative‑free) 4–6 times daily.
• Lubricating ointment at night.
• Moisture‑retaining goggles or an eye patch to prevent corneal drying.

Physical therapy & facial exercises

Gentle facial massage and exercises (e.g., raising eyebrows, smiling, puckering lips) performed 3–4 times daily can help maintain muscle tone and prevent synkinesis (abnormal muscle movements) during recovery.

Surgical interventions

• Decompression surgery: Rare; considered only in severe cases (<10 % of patients) when there is evidence of nerve compression on imaging and no improvement after 2–3 weeks of steroids.
• Botulinum toxin injections: Useful for managing facial synkinesis or contractures that develop during the chronic phase.

Adjunctive measures

• Heat therapy (warm compresses) for 10‑15 minutes, 3–4 times daily, may improve circulation.
• Adequate nutrition, especially vitamin B‑complex and omega‑3 fatty acids, supports nerve health (though not proven to alter outcomes).

Living with Facial Nerve Palsy (Bell’s Palsy)

Most people regain normal or near‑normal facial function within 3–6 months, but coping strategies can ease the acute phase and improve quality of life.

Daily management tips

• Eye care: Apply lubricating drops before any activity that may cause eye dryness (reading, computer work). Use an eye shield while sleeping.
• Speech and eating: Take small bites, chew slowly, and sip water frequently. Use a straw if drooling is problematic.
• Facial exercise routine: Follow a structured program (e.g., “Smile‑Stretch‑Hold” for 5 seconds, repeat 10 times). Physical therapists specializing in facial rehabilitation can provide personalized plans.
• Emotional support: Facial changes can affect self‑image. Consider counseling, support groups, or online communities (e.g., Bell’s Palsy Association).
• Skin care: The affected side may become dry or develop acne. Use gentle, non‑comedogenic moisturizers.
• Protect the unaffected side: In severe cases, the unaffected side can become over‑used; be mindful of muscle fatigue.

When to follow‑up

Schedule a follow‑up appointment with your neurologist or otolaryngologist within 1 week of starting steroids, then at 4‑6 weeks to assess recovery. If there is no improvement after 3 months, referral to a facial‑rehabilitation specialist is warranted.

Prevention

Because Bell’s palsy is largely idiopathic, absolute prevention is impossible, but risk can be lowered by:

• Managing chronic conditions (tight glycemic control in diabetes, blood‑pressure control).
• Practicing good hand hygiene and avoiding exposure to known viral triggers (e.g., cold sores).
• Receiving the Lyme disease vaccine (where available) if you live in endemic regions.
• Maintaining a healthy immune system through balanced diet, regular exercise, adequate sleep, and stress reduction.
• Pregnant women: Regular prenatal care and monitoring of hypertension or gestational diabetes.

Complications

When untreated or poorly managed, Bell’s palsy can lead to:

• Persistent facial weakness: Up to 15 % may have incomplete recovery after 6 months.
• Synkinesis: Involuntary facial movements (e.g., eye closure when smiling).
• Corneal ulceration or scarring: From chronic eye exposure.
• Facial muscle atrophy: Long‑standing disuse.
• Psychological impact: Depression, anxiety, and social withdrawal.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Bell’s Palsy.” Updated 2023. https://www.mayoclinic.org
2. National Institute of Neurological Disorders and Stroke. “Bell’s Palsy Fact Sheet.” 2022. https://www.ninds.nih.gov
3. Cleveland Clinic. “Bell’s Palsy in Pregnancy.” 2023. https://my.clevelandclinic.org
4. O'Leary et al. “Diabetes as a risk factor for facial nerve palsy.” *Diabetes Care*, 2021;44:1825‑1832.
5. American Academy of Neurology. “Practice guideline: Bell’s palsy.” *Neurology*, 2020;94:467‑475.
6. Sumrani et al. “Antiviral therapy for Bell’s palsy: a systematic review.” *JAMA Otolaryngol Head Neck Surg*, 2022;148:342‑350.

```